Stock Screener

Companies in the Healthcare sector

As of , the Kaplio screener finds 245 companies in the Healthcare sector above $2 billion with consistent data.

  1. Eli Lilly and Company (LLY) — cheap, P/E 38.4
  2. Johnson & Johnson (JNJ) — expensive, P/E 29.7
  3. AbbVie Inc. (ABBV) — expensive, P/E 74.0
  4. Merck & Co., Inc. (MRK) — fairly priced, P/E 115
  5. UnitedHealth Group Incorporated (UNH) — fairly priced, P/E 23.9
  6. Novartis AG (NVS) — fairly priced, P/E 21.3
  7. AstraZeneca PLC (AZN) — cheap, P/E 23.4
  8. Thermo Fisher Scientific Inc. (TMO) — fairly priced, P/E 35.2
  9. Amgen Inc. (AMGN) — expensive, P/E 25.0
  10. Gilead Sciences, Inc. (GILD) — no verdict, no P/E
  11. Novo Nordisk A/S (NVO) — cheap, P/E 9.4
  12. Abbott Laboratories (ABT) — fairly priced, P/E 31.4
  13. Pfizer Inc. (PFE) — no verdict, P/E 36.7
  14. Danaher Corporation (DHR) — fairly priced, P/E 38.0
  15. Intuitive Surgical, Inc. (ISRG) — cheap, P/E 44.6
  16. Vertex Pharmaceuticals Incorporated (VRTX) — no verdict, P/E 29.4
  17. Bristol-Myers Squibb Company (BMY) — cheap, P/E 13.5
  18. Medtronic plc (MDT) — cheap, P/E 21.3
  19. CVS Health Corp. (CVS) — expensive, P/E 22.9
  20. McKesson Corporation (MCK) — cheap, P/E 24.0
  21. Stryker Corporation (SYK) — cheap, P/E 28.5
  22. Sanofi (SNY) — expensive, P/E 21.7
  23. GSK plc (GSK) — expensive, P/E 14.8
  24. HCA Healthcare, Inc. (HCA) — fairly priced, P/E 14.3
  25. Elevance Health Inc. (ELV) — fairly priced, P/E 17.2
  26. Regeneron Pharmaceuticals, Inc. (REGN) — no verdict, P/E 17.6
  27. Moderna, Inc. (MRNA) — no verdict, no P/E
  28. Cigna Corporation (CI) — cheap, P/E 11.2
  29. Boston Scientific Corporation (BSX) — cheap, P/E 17.2
  30. Cencora, Inc. (COR) — fairly priced, P/E 23.0
  31. Takeda Pharmaceutical Company Limited (TAK) — expensive, P/E 49.4
  32. Natera, Inc. (NTRA) — no verdict, no P/E
  33. argenx SE (ARGX) — no verdict, P/E 33.5
  34. Cardinal Health, Inc. (CAH) — fairly priced, P/E 31.6
  35. Edwards Lifesciences Corporation (EW) — fairly priced, P/E 48.9
  36. Becton, Dickinson and Company (BDX) — fairly priced, P/E 53.3
  37. Agilent Technologies, Inc. (A) — fairly priced, P/E 33.0
  38. Humana Inc. (HUM) — expensive, P/E 36.8
  39. Teva Pharmaceutical Industries Limited (TEVA) — expensive, P/E 62.4
  40. Revolution Medicines, Inc. (RVMD) — no verdict, no P/E

and 205 more

See the full list in the screener

Filter the companies above $2 billion with consistent data by the Kaplio lights, P/E, ROE, dividend and more.

← Back to Markets

Other markets tools